The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl) -N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation

Scott, G.S., Kean, R.B., Mikheeva, T., Fabis, M.J., Mabley, J.G., Szabo, C. and Hooper, D.C. (2004) The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl) -N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation Journal of Pharmacology and Experimental Therapeutics, 310 . pp. 1053-1061. ISSN 1521-0103

Full text not available from this repository.


Item Type:Journal article
Subjects:B000 Health Professions > B200 Pharmacology Toxicology and Pharmacy > B210 Pharmacology and Therapeutics
DOI (a stable link to the resource):10.1124/jpet.103.063214
Faculties:Faculty of Science and Engineering > School of Pharmacy and Biomolecular Sciences
ID Code:809
Deposited By:editor spbs
Deposited On:01 Dec 2006
Last Modified:17 Apr 2014 15:27

Repository Staff Only: item control page